{"type":"trials","record":{"id":87110,"source_id":"isrctn","external_id":"ISRCTN16865847","title":"Exploring the benefits of wearable electronic vision enhancement systems for people with age-related loss of central vision","brief_summary":"Compared with conventional low-vision solutions, wearable electronic vision enhancement systems (wEVES) will: Hypothesis 1: Be the preferred solution and be used more often than existing solutions. Hypothesis 2: Reduce self-reported activity limitation. Hypothesis 3: Be more versatile, allowing use for tasks without a current solution. Hypothesis 4: Improve Vision Related Quality of Life (VRQoL) Hypothesis 5: Be a cost-effective solution in improving the QoL for people with AMD","overall_status":"Completed","phases":["Not Applicable"],"study_type":"Interventional","sponsor":"Macular Society","enrollment":34,"countries":["United Kingdom","England"],"start_date":"2023-04-01","completion_date":"2024-05-31","last_update_date":"2025-09-04","source_url":"https://www.isrctn.com/ISRCTN16865847","editorial_summary":"A registered Not Applicable study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.","first_seen_at":"2026-09-25T03:46:39.792962+00:00","last_seen_at":"2026-09-25T03:46:39.551+00:00","metadata":{"sex":"All","age_range":"Adult","comparator":null,"attribution":"Source: ISRCTN ISRCTN16865847; retrieved 2026-09-25","interventions":["Eyedaptic Eye5","Device"],"reuse_license":"Registry contribution CC BY 4.0; generated metadata CC0","registry_source":"ISRCTN","outcome_measures":["The following primary outcome measurements will be taken at baseline, week 8 and week 16: 1. Activity limitation, task…","1. Adverse effects of the wearable electronic vision enhancement system (wEVES) measured using the Virtual Reality sick…"],"design_description":"Interventional","source_has_results":false},"controlled_terms":["People with age-related macular degeneration as the principal cause of vision impairment.","This is a 16-week crossover study to assess the effect of adding a wearable electronic vision enhancement system (wEVES…","Qualitative results","Study website","Participant information sheet","Eyedaptic Eye5","Device"],"relevance_confidence":70,"source_quality_score":98,"freshness_score":65,"publication_state":"published","match_explanation":"Source terminology contains: age-related macular degeneration.","quality_checked_at":"2026-09-25T03:46:42.633202+00:00","duplicate_cluster_key":"id:isrctn16865847","duplicate_of_id":null,"evidence_snapshot":{"status":"structured","version":1,"duration":"2023-04-01 to 2024-05-31","comparator":null,"confidence":"structured-source","population":"All · Adult","provenance":{"duration":"start_date and completion_date","comparator":"registry arm fields","population":"registry eligibility fields","intervention":"registry intervention fields","participants":"enrollment","study_design":"study_type and registry design fields","evidence_stage":"phases","reported_outcome":"not available","outcomes_measured":"registry outcome-measure fields"},"generated_at":"2026-09-25T03:46:39.562Z","intervention":["Eyedaptic Eye5","Device"],"participants":34,"study_design":"Interventional","subject_scope":"Human clinical study registration","evidence_stage":"Not Applicable","safety_context":"Eligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians.","source_support":"Structured registry protocol metadata; no finding-level conclusion is generated.","main_limitation":"This is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.","reported_outcome":null,"outcomes_measured":["The following primary outcome measurements will be taken at baseline, week 8 and week 16: 1. Activity limitation, task…","1. Adverse effects of the wearable electronic vision enhancement system (wEVES) measured using the Virtual Reality sick…"],"regulatory_context":"Trial registration is not regulatory approval and does not establish that an intervention is available."},"clinical_trial_topics":[{"topic_slug":"vision-aging","is_published":true,"match_reasons":["Source terminology contains: age-related macular degeneration.","Title supplies longevity context: age-related.","Study type is explicitly identified as Interventional."],"matched_fields":["controlled terminology","title context","study type"],"relevance_score":70,"intelligence_topics":{"name":"Vision ageing","slug":"vision-aging"}}],"content_sources":{"name":"ISRCTN Registry","homepage_url":"https://www.isrctn.com/"}},"canonical_url":"https://www.immortal.life/trials/87110","automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}